nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—Transient ischaemic attack—Varenicline—nicotine dependence	0.0181	0.0265	CcSEcCtD
Zolmitriptan—Osteoporosis—Varenicline—nicotine dependence	0.0163	0.0239	CcSEcCtD
Zolmitriptan—Parosmia—Varenicline—nicotine dependence	0.0141	0.0206	CcSEcCtD
Zolmitriptan—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.014	0.0204	CcSEcCtD
Zolmitriptan—Intestinal obstruction—Varenicline—nicotine dependence	0.0134	0.0196	CcSEcCtD
Zolmitriptan—Haematemesis—Varenicline—nicotine dependence	0.0132	0.0193	CcSEcCtD
Zolmitriptan—Mania—Varenicline—nicotine dependence	0.0126	0.0184	CcSEcCtD
Zolmitriptan—Menorrhagia—Varenicline—nicotine dependence	0.0124	0.0181	CcSEcCtD
Zolmitriptan—Scotoma—Varenicline—nicotine dependence	0.0121	0.0176	CcSEcCtD
Zolmitriptan—Gingivitis—Varenicline—nicotine dependence	0.0117	0.017	CcSEcCtD
Zolmitriptan—Tenderness—Varenicline—nicotine dependence	0.0105	0.0153	CcSEcCtD
Zolmitriptan—Chest discomfort—Varenicline—nicotine dependence	0.0103	0.0151	CcSEcCtD
Zolmitriptan—Thinking abnormal—Varenicline—nicotine dependence	0.01	0.0146	CcSEcCtD
Zolmitriptan—Lacrimation increased—Varenicline—nicotine dependence	0.00994	0.0145	CcSEcCtD
Zolmitriptan—HTR1F—Monoamine GPCRs—DRD2—nicotine dependence	0.00973	0.04	CbGpPWpGaD
Zolmitriptan—Coordination abnormal—Varenicline—nicotine dependence	0.00932	0.0136	CcSEcCtD
Zolmitriptan—Blood pressure increased—Varenicline—nicotine dependence	0.00916	0.0134	CcSEcCtD
Zolmitriptan—Abnormal dreams—Varenicline—nicotine dependence	0.00905	0.0132	CcSEcCtD
Zolmitriptan—Eructation—Varenicline—nicotine dependence	0.009	0.0131	CcSEcCtD
Zolmitriptan—Salivary hypersecretion—Varenicline—nicotine dependence	0.00889	0.013	CcSEcCtD
Zolmitriptan—Sumatriptan—DRD2—nicotine dependence	0.00862	1	CrCbGaD
Zolmitriptan—Photophobia—Varenicline—nicotine dependence	0.0086	0.0126	CcSEcCtD
Zolmitriptan—Dry eye—Varenicline—nicotine dependence	0.00846	0.0124	CcSEcCtD
Zolmitriptan—Oesophagitis—Varenicline—nicotine dependence	0.00837	0.0122	CcSEcCtD
Zolmitriptan—HTR1F—brain—nicotine dependence	0.00833	0.131	CbGeAlD
Zolmitriptan—Urine output increased—Varenicline—nicotine dependence	0.00828	0.0121	CcSEcCtD
Zolmitriptan—HTR1F—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00818	0.0336	CbGpPWpGaD
Zolmitriptan—Hypertonia—Varenicline—nicotine dependence	0.00803	0.0117	CcSEcCtD
Zolmitriptan—Mental disability—Varenicline—nicotine dependence	0.00795	0.0116	CcSEcCtD
Zolmitriptan—Euphoric mood—Varenicline—nicotine dependence	0.00787	0.0115	CcSEcCtD
Zolmitriptan—Lymphadenopathy—Varenicline—nicotine dependence	0.00779	0.0114	CcSEcCtD
Zolmitriptan—Polyuria—Varenicline—nicotine dependence	0.00757	0.0111	CcSEcCtD
Zolmitriptan—Eczema—Varenicline—nicotine dependence	0.0074	0.0108	CcSEcCtD
Zolmitriptan—Eye pain—Varenicline—nicotine dependence	0.00736	0.0108	CcSEcCtD
Zolmitriptan—Amnesia—Varenicline—nicotine dependence	0.00707	0.0103	CcSEcCtD
Zolmitriptan—Increased appetite—Varenicline—nicotine dependence	0.00707	0.0103	CcSEcCtD
Zolmitriptan—Atrial fibrillation—Varenicline—nicotine dependence	0.00701	0.0103	CcSEcCtD
Zolmitriptan—Thirst—Varenicline—nicotine dependence	0.00698	0.0102	CcSEcCtD
Zolmitriptan—HTR1B—cardiovascular system—nicotine dependence	0.00696	0.109	CbGeAlD
Zolmitriptan—Arthritis—Varenicline—nicotine dependence	0.00684	0.00999	CcSEcCtD
Zolmitriptan—HTR1D—cardiovascular system—nicotine dependence	0.00674	0.105	CbGeAlD
Zolmitriptan—Osteoarthritis—Varenicline—nicotine dependence	0.00665	0.00971	CcSEcCtD
Zolmitriptan—HTR1F—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00664	0.0273	CbGpPWpGaD
Zolmitriptan—Affect lability—Varenicline—nicotine dependence	0.00654	0.00956	CcSEcCtD
Zolmitriptan—Migraine—Varenicline—nicotine dependence	0.00654	0.00956	CcSEcCtD
Zolmitriptan—Psychotic disorder—Varenicline—nicotine dependence	0.00649	0.00949	CcSEcCtD
Zolmitriptan—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00636	0.0261	CbGpPWpGaD
Zolmitriptan—Irritability—Varenicline—nicotine dependence	0.00634	0.00927	CcSEcCtD
Zolmitriptan—Mood swings—Varenicline—nicotine dependence	0.0063	0.0092	CcSEcCtD
Zolmitriptan—HTR1D—Monoamine GPCRs—DRD2—nicotine dependence	0.00622	0.0256	CbGpPWpGaD
Zolmitriptan—HTR1B—Monoamine GPCRs—DRD2—nicotine dependence	0.00609	0.025	CbGpPWpGaD
Zolmitriptan—Gastritis—Varenicline—nicotine dependence	0.00588	0.0086	CcSEcCtD
Zolmitriptan—MAOA—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0058	0.0238	CbGpPWpGaD
Zolmitriptan—Dysphagia—Varenicline—nicotine dependence	0.00574	0.0084	CcSEcCtD
Zolmitriptan—HTR1A—cardiovascular system—nicotine dependence	0.00562	0.0879	CbGeAlD
Zolmitriptan—Angina pectoris—Varenicline—nicotine dependence	0.0056	0.00818	CcSEcCtD
Zolmitriptan—Bronchitis—Varenicline—nicotine dependence	0.00552	0.00807	CcSEcCtD
Zolmitriptan—HTR1B—midbrain—nicotine dependence	0.00543	0.0851	CbGeAlD
Zolmitriptan—Pollakiuria—Varenicline—nicotine dependence	0.00531	0.00776	CcSEcCtD
Zolmitriptan—HTR1D—midbrain—nicotine dependence	0.00526	0.0824	CbGeAlD
Zolmitriptan—Photosensitivity reaction—Varenicline—nicotine dependence	0.00524	0.00766	CcSEcCtD
Zolmitriptan—HTR1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00523	0.0215	CbGpPWpGaD
Zolmitriptan—Weight increased—Varenicline—nicotine dependence	0.00523	0.00764	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Varenicline—nicotine dependence	0.00518	0.00757	CcSEcCtD
Zolmitriptan—MAOA—cardiovascular system—nicotine dependence	0.00513	0.0803	CbGeAlD
Zolmitriptan—HTR1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00512	0.0211	CbGpPWpGaD
Zolmitriptan—Acute coronary syndrome—Varenicline—nicotine dependence	0.00505	0.00738	CcSEcCtD
Zolmitriptan—Myocardial infarction—Varenicline—nicotine dependence	0.00502	0.00734	CcSEcCtD
Zolmitriptan—Stomatitis—Varenicline—nicotine dependence	0.00499	0.0073	CcSEcCtD
Zolmitriptan—Conjunctivitis—Varenicline—nicotine dependence	0.00498	0.00728	CcSEcCtD
Zolmitriptan—Epistaxis—Varenicline—nicotine dependence	0.00483	0.00706	CcSEcCtD
Zolmitriptan—Sinusitis—Varenicline—nicotine dependence	0.00481	0.00702	CcSEcCtD
Zolmitriptan—Bradycardia—Varenicline—nicotine dependence	0.00468	0.00684	CcSEcCtD
Zolmitriptan—HTR1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00464	0.0191	CbGpPWpGaD
Zolmitriptan—Hallucination—Varenicline—nicotine dependence	0.00458	0.00669	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Varenicline—nicotine dependence	0.00458	0.00669	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Varenicline—nicotine dependence	0.00454	0.00664	CcSEcCtD
Zolmitriptan—Oedema peripheral—Varenicline—nicotine dependence	0.00453	0.00662	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Varenicline—nicotine dependence	0.00452	0.0066	CcSEcCtD
Zolmitriptan—Urethral disorder—Varenicline—nicotine dependence	0.00451	0.00659	CcSEcCtD
Zolmitriptan—HTR1A—midbrain—nicotine dependence	0.00439	0.0687	CbGeAlD
Zolmitriptan—Tinnitus—Varenicline—nicotine dependence	0.00429	0.00627	CcSEcCtD
Zolmitriptan—Cardiac disorder—Varenicline—nicotine dependence	0.00427	0.00624	CcSEcCtD
Zolmitriptan—HTR1D—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00425	0.0175	CbGpPWpGaD
Zolmitriptan—Angiopathy—Varenicline—nicotine dependence	0.00417	0.0061	CcSEcCtD
Zolmitriptan—HTR1B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00416	0.0171	CbGpPWpGaD
Zolmitriptan—Immune system disorder—Varenicline—nicotine dependence	0.00415	0.00607	CcSEcCtD
Zolmitriptan—Chills—Varenicline—nicotine dependence	0.00413	0.00603	CcSEcCtD
Zolmitriptan—Arrhythmia—Varenicline—nicotine dependence	0.00411	0.006	CcSEcCtD
Zolmitriptan—HTR1F—GPCR ligand binding—TAS2R16—nicotine dependence	0.00402	0.0165	CbGpPWpGaD
Zolmitriptan—MAOA—midbrain—nicotine dependence	0.00401	0.0627	CbGeAlD
Zolmitriptan—Erythema—Varenicline—nicotine dependence	0.004	0.00585	CcSEcCtD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00399	0.0164	CbGpPWpGaD
Zolmitriptan—Dysgeusia—Varenicline—nicotine dependence	0.00392	0.00573	CcSEcCtD
Zolmitriptan—HTR1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0039	0.016	CbGpPWpGaD
Zolmitriptan—Back pain—Varenicline—nicotine dependence	0.00387	0.00566	CcSEcCtD
Zolmitriptan—Muscle spasms—Varenicline—nicotine dependence	0.00385	0.00562	CcSEcCtD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00378	0.0155	CbGpPWpGaD
Zolmitriptan—Tremor—Varenicline—nicotine dependence	0.00375	0.00548	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Varenicline—nicotine dependence	0.00371	0.00543	CcSEcCtD
Zolmitriptan—Agitation—Varenicline—nicotine dependence	0.00368	0.00538	CcSEcCtD
Zolmitriptan—Angioedema—Varenicline—nicotine dependence	0.00366	0.00535	CcSEcCtD
Zolmitriptan—Malaise—Varenicline—nicotine dependence	0.00361	0.00528	CcSEcCtD
Zolmitriptan—Vertigo—Varenicline—nicotine dependence	0.0036	0.00526	CcSEcCtD
Zolmitriptan—Syncope—Varenicline—nicotine dependence	0.00359	0.00525	CcSEcCtD
Zolmitriptan—Palpitations—Varenicline—nicotine dependence	0.00354	0.00517	CcSEcCtD
Zolmitriptan—Loss of consciousness—Varenicline—nicotine dependence	0.00352	0.00514	CcSEcCtD
Zolmitriptan—Cough—Varenicline—nicotine dependence	0.00349	0.0051	CcSEcCtD
Zolmitriptan—Convulsion—Varenicline—nicotine dependence	0.00347	0.00507	CcSEcCtD
Zolmitriptan—Hypertension—Varenicline—nicotine dependence	0.00346	0.00505	CcSEcCtD
Zolmitriptan—HTR1B—brain—nicotine dependence	0.00341	0.0535	CbGeAlD
Zolmitriptan—Myalgia—Varenicline—nicotine dependence	0.00341	0.00498	CcSEcCtD
Zolmitriptan—Arthralgia—Varenicline—nicotine dependence	0.00341	0.00498	CcSEcCtD
Zolmitriptan—Chest pain—Varenicline—nicotine dependence	0.00341	0.00498	CcSEcCtD
Zolmitriptan—Anxiety—Varenicline—nicotine dependence	0.0034	0.00496	CcSEcCtD
Zolmitriptan—Discomfort—Varenicline—nicotine dependence	0.00337	0.00492	CcSEcCtD
Zolmitriptan—Dry mouth—Varenicline—nicotine dependence	0.00333	0.00487	CcSEcCtD
Zolmitriptan—HTR1D—brain—nicotine dependence	0.00331	0.0518	CbGeAlD
Zolmitriptan—Oedema—Varenicline—nicotine dependence	0.00327	0.00477	CcSEcCtD
Zolmitriptan—Infection—Varenicline—nicotine dependence	0.00325	0.00474	CcSEcCtD
Zolmitriptan—Shock—Varenicline—nicotine dependence	0.00321	0.0047	CcSEcCtD
Zolmitriptan—Nervous system disorder—Varenicline—nicotine dependence	0.0032	0.00468	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Varenicline—nicotine dependence	0.0032	0.00467	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00319	0.0131	CbGpPWpGaD
Zolmitriptan—Tachycardia—Varenicline—nicotine dependence	0.00319	0.00466	CcSEcCtD
Zolmitriptan—Skin disorder—Varenicline—nicotine dependence	0.00317	0.00464	CcSEcCtD
Zolmitriptan—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00317	0.013	CbGpPWpGaD
Zolmitriptan—Hyperhidrosis—Varenicline—nicotine dependence	0.00316	0.00462	CcSEcCtD
Zolmitriptan—Anorexia—Varenicline—nicotine dependence	0.00311	0.00455	CcSEcCtD
Zolmitriptan—MAOA—Biological oxidations—CYP2A7—nicotine dependence	0.00308	0.0127	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—CHRNB3—nicotine dependence	0.00305	0.0126	CbGpPWpGaD
Zolmitriptan—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00298	0.00435	CcSEcCtD
Zolmitriptan—Insomnia—Varenicline—nicotine dependence	0.00295	0.00432	CcSEcCtD
Zolmitriptan—Dyspnoea—Varenicline—nicotine dependence	0.00291	0.00426	CcSEcCtD
Zolmitriptan—Somnolence—Varenicline—nicotine dependence	0.0029	0.00424	CcSEcCtD
Zolmitriptan—MAOA—Neuronal System—CHRNA6—nicotine dependence	0.00289	0.0119	CbGpPWpGaD
Zolmitriptan—Dyspepsia—Varenicline—nicotine dependence	0.00288	0.0042	CcSEcCtD
Zolmitriptan—Decreased appetite—Varenicline—nicotine dependence	0.00284	0.00415	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00282	0.00412	CcSEcCtD
Zolmitriptan—HTR1F—G alpha (i) signalling events—OPRM1—nicotine dependence	0.0028	0.0115	CbGpPWpGaD
Zolmitriptan—Pain—Varenicline—nicotine dependence	0.00279	0.00408	CcSEcCtD
Zolmitriptan—Constipation—Varenicline—nicotine dependence	0.00279	0.00408	CcSEcCtD
Zolmitriptan—HTR1A—brain—nicotine dependence	0.00276	0.0431	CbGeAlD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00273	0.0112	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00272	0.0112	CbGpPWpGaD
Zolmitriptan—Feeling abnormal—Varenicline—nicotine dependence	0.00269	0.00393	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Varenicline—nicotine dependence	0.00267	0.0039	CcSEcCtD
Zolmitriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00264	0.0109	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00262	0.0108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0026	0.0107	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0026	0.0107	CbGpPWpGaD
Zolmitriptan—Urticaria—Varenicline—nicotine dependence	0.0026	0.00379	CcSEcCtD
Zolmitriptan—Body temperature increased—Varenicline—nicotine dependence	0.00258	0.00377	CcSEcCtD
Zolmitriptan—Abdominal pain—Varenicline—nicotine dependence	0.00258	0.00377	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00257	0.0106	CbGpPWpGaD
Zolmitriptan—MAOA—brain—nicotine dependence	0.00252	0.0394	CbGeAlD
Zolmitriptan—HTR1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00252	0.0103	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00243	0.01	CbGpPWpGaD
Zolmitriptan—Hypersensitivity—Varenicline—nicotine dependence	0.00241	0.00352	CcSEcCtD
Zolmitriptan—Asthenia—Varenicline—nicotine dependence	0.00234	0.00343	CcSEcCtD
Zolmitriptan—Pruritus—Varenicline—nicotine dependence	0.00231	0.00338	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00227	0.00934	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Varenicline—nicotine dependence	0.00224	0.00327	CcSEcCtD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00223	0.00915	CbGpPWpGaD
Zolmitriptan—Dizziness—Varenicline—nicotine dependence	0.00216	0.00316	CcSEcCtD
Zolmitriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00214	0.0088	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00213	0.00876	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—GABRA4—nicotine dependence	0.00209	0.0086	CbGpPWpGaD
Zolmitriptan—Vomiting—Varenicline—nicotine dependence	0.00208	0.00304	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—TAS2R16—nicotine dependence	0.00206	0.00848	CbGpPWpGaD
Zolmitriptan—Rash—Varenicline—nicotine dependence	0.00206	0.00301	CcSEcCtD
Zolmitriptan—Dermatitis—Varenicline—nicotine dependence	0.00206	0.00301	CcSEcCtD
Zolmitriptan—Headache—Varenicline—nicotine dependence	0.00205	0.00299	CcSEcCtD
Zolmitriptan—HTR1F—G alpha (i) signalling events—DRD2—nicotine dependence	0.00202	0.00832	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—CHRNB4—nicotine dependence	0.00201	0.00825	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00198	0.00816	CbGpPWpGaD
Zolmitriptan—Nausea—Varenicline—nicotine dependence	0.00194	0.00284	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00194	0.00796	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00192	0.00788	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00188	0.00772	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—CHRNA5—nicotine dependence	0.00187	0.00767	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00181	0.00745	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00179	0.00736	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—FGD1—nicotine dependence	0.00178	0.00733	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00175	0.0072	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00175	0.00718	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—OPRM1—nicotine dependence	0.00169	0.00697	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00166	0.00683	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00165	0.00676	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00163	0.00669	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—FGD1—nicotine dependence	0.00162	0.00666	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00161	0.00661	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00159	0.00652	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—CHRNA3—nicotine dependence	0.00152	0.00625	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00145	0.00597	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00142	0.00585	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00142	0.00585	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00139	0.00573	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—CHRNB2—nicotine dependence	0.00134	0.0055	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00134	0.00549	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00132	0.00542	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—DRD2—nicotine dependence	0.00129	0.00532	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00129	0.00531	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—DRD2—nicotine dependence	0.00127	0.00521	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00124	0.00509	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—DRD2—nicotine dependence	0.00123	0.00504	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TAS2R16—nicotine dependence	0.00122	0.00501	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—CHRNA4—nicotine dependence	0.00122	0.005	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00121	0.00496	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0012	0.00494	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00118	0.00483	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00114	0.00469	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00114	0.00467	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00112	0.00461	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—FGD1—nicotine dependence	0.00112	0.00459	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00108	0.00446	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00108	0.00445	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00106	0.00436	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00106	0.00436	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.00104	0.00426	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00103	0.00423	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.00101	0.00417	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00101	0.00414	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000984	0.00405	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000965	0.00397	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—OPRM1—nicotine dependence	0.000958	0.00394	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—FGD1—nicotine dependence	0.000956	0.00393	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000896	0.00368	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—OPRM1—nicotine dependence	0.00087	0.00358	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00085	0.0035	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKR1B10—nicotine dependence	0.000845	0.00347	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000808	0.00332	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.000784	0.00322	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000779	0.0032	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000772	0.00317	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000767	0.00316	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000767	0.00315	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000763	0.00314	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—DRD2—nicotine dependence	0.000692	0.00285	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—DRD2—nicotine dependence	0.000629	0.00258	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000612	0.00252	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGD1—nicotine dependence	0.000612	0.00251	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.0006	0.00247	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGD1—nicotine dependence	0.000599	0.00246	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—WASF2—nicotine dependence	0.000595	0.00245	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000584	0.0024	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000581	0.00239	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—WASF1—nicotine dependence	0.000571	0.00235	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000556	0.00229	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000545	0.00224	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	0.00054	0.00222	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000529	0.00217	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP2A7—nicotine dependence	0.000527	0.00217	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—OPRM1—nicotine dependence	0.000514	0.00211	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000457	0.00188	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGD1—nicotine dependence	0.000456	0.00188	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000443	0.00182	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000434	0.00178	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000415	0.00171	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000403	0.00166	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	0.000402	0.00165	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	0.000394	0.00162	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—WASF2—nicotine dependence	0.000381	0.00156	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—WASF2—nicotine dependence	0.000373	0.00153	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—DRD2—nicotine dependence	0.000371	0.00153	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—WASF1—nicotine dependence	0.000365	0.0015	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—WASF1—nicotine dependence	0.000357	0.00147	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	0.00033	0.00136	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	0.000329	0.00135	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	0.000322	0.00132	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	0.0003	0.00123	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—WASF2—nicotine dependence	0.000284	0.00117	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—WASF1—nicotine dependence	0.000272	0.00112	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	0.000245	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—DRD2—nicotine dependence	0.000238	0.000976	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—DRD2—nicotine dependence	0.000233	0.000956	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000194	0.000799	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—DRD2—nicotine dependence	0.000177	0.000728	CbGpPWpGaD
